We have reinstated our forecasts & valuation following a change in lead analyst and recent trading and strategy updates. We expect solid growth in the Products and Services divisions on improving margins, with significant potential upside through investment in Leveraged R&D. Our revised valuation implies a target price of 194p (from 246p). We believe that the current price represents an attractive entry point into what we see as an exciting growth story. We recommend a Buy.